Literature DB >> 8798052

The non-ionic isotonic contrast agents. Perspectives and controversies.

P Dawson1.   

Abstract

The non-ionic isotonic contrast agents represent a new class of intravascular iodinated x-ray contrast agents. They are highly hydrophilic, resulting in low chemotoxicity, are non-ionic, thereby eliminating Coulomb interactions, and are formulated in solutions iso-osmolar with the respective body fluids. Invitro testing, organ specific toxicity studies and overall systemic toxicity assessments such as LD50 measurements all point to an excellent toxicity profile. This justify their application in high dose procedures where their low toxicity may be distinctly advantageous. Their iso-osmolality, possibly combined with a slower diffusion of the larger molecules across vessel walls and out of the vascular space, may play a significant role in producing better quality venous phase images following arteriography and arterial phase images following venous injection. This may have implications for the quality of IV-DSA, the venous phase of arteriograms, CT-portography and spiral CT arteriography.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798052     DOI: 10.1007/bf02342568

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  10 in total

1.  Evaluation of renal function with delayed CT after injection of nonionic monomeric and dimeric contrast media in healthy volunteers.

Authors:  J A Jakobsen; B Lundby; D T Kristoffersen; K W Borch; J K Hald; K J Berg
Journal:  Radiology       Date:  1992-02       Impact factor: 11.105

2.  The non-ionic dimers: a new class of contrast agents.

Authors:  P Dawson; M Howell
Journal:  Br J Radiol       Date:  1986-10       Impact factor: 3.039

3.  Vascular endothelial injury by intravascular contrast agents.

Authors:  H L Beynon; M J Walport; P Dawson
Journal:  Invest Radiol       Date:  1994-06       Impact factor: 6.016

4.  Iodixanol in excretory urography: initial clinical experience with a nonionic, dimeric (ratio 6:1) contrast medium. Work in progress.

Authors:  M L Gavant; R L Siegle
Journal:  Radiology       Date:  1992-05       Impact factor: 11.105

5.  Histamine release induced by radiographic contrast media. Comparison between pulmonary and peritoneal mast cells derived from normotensive and spontaneously hypertensive rats.

Authors:  E U Amon; M Ennis; W Lorenz; M Schnabel; C Schneider
Journal:  Int Arch Allergy Appl Immunol       Date:  1990

6.  Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml.

Authors:  K Tveit; K D Bolz; B Bolstad; T Haugland; K J Berg; T Skjaerpe; Y F Kloster
Journal:  Acta Radiol       Date:  1994-11       Impact factor: 1.990

7.  Effects of intravascular contrast media on blood-brain barrier. Comparison between iothalamate, iohexol, iopentol and iodixanol.

Authors:  A Aulie Michelet
Journal:  Acta Radiol       Date:  1987 May-Jun       Impact factor: 1.990

8.  Iodixanol in cardioangiography in patients with coronary artery disease. Tolerability, cardiac and renal effects.

Authors:  N E Kløw; K Levorstad; K J Berg; U Brodahl; K Endresen; D T Kristoffersen; B Laake; S Simonsen; A J Tofte; B Lundby
Journal:  Acta Radiol       Date:  1993-01       Impact factor: 1.990

9.  The persistent computed tomography nephrogram: its significance in the diagnosis of contrast-associated nephrotoxicity.

Authors:  L Love; M S Johnson; M E Bresler; J E Nelson; M C Olson; M E Flisak
Journal:  Br J Radiol       Date:  1994-10       Impact factor: 3.039

10.  Nonionic dimer: development and initial testing of an intrathecal contrast agent.

Authors:  M Sovak; R Ranganathan; U Speck
Journal:  Radiology       Date:  1982-01       Impact factor: 11.105

  10 in total
  4 in total

1.  Patient discomfort associated with the use of intra-arterial iodinated contrast media: a meta-analysis of comparative randomized controlled trials.

Authors:  Peter A McCullough; Patrizio Capasso
Journal:  BMC Med Imaging       Date:  2011-05-24       Impact factor: 1.930

Review 2.  Surveillance of patients post-endovascular aneurysm repair.

Authors:  P Sharma; C Kyriakides
Journal:  Postgrad Med J       Date:  2007-12       Impact factor: 2.401

3.  Post-marketing surveillance study with iodixanol in 20 185 Chinese patients from routine clinical practices.

Authors:  B-C Zhang; L Hou; B Lv; Y-W Xu
Journal:  Br J Radiol       Date:  2013-12-19       Impact factor: 3.039

4.  The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM).

Authors:  Jai-Sing Yang; Yan-Ru Peng; Shih-Chang Tsai; Yeu-Sheng Tyan; Chi-Cheng Lu; Hong-Yi Chiu; Yu-Jen Chiu; Sheng-Chu Kuo; Yuh-Feng Tsai; Ping-Chin Lin; Fuu-Jen Tsai
Journal:  Biomedicine (Taipei)       Date:  2018-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.